Skip to main content
The Maple Markets

Canadian Securities Exchange (CSE) · BUX.CN · ISIN CA09073K1084

BioMark Diagnostics Inc.

0.5000 CAD

+0.01(+2.04%)up

Previous close · Sep 17, 17:04 ET

Data last updated: (2 d ago)· Delayed exchange data

Sign in to add to portfolio

BioMark Diagnostics Inc. (BUX.CN) trades on the Canadian Securities Exchange and operates in the Medical - Diagnostics & Research industry. Its market capitalisation is approximately 51.49M CAD. The company reports around 9 employees. Its ISIN is CA09073K1084. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Canadian Securities Exchange (CSE)

ISIN

CA09073K1084

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

CA

Market cap

52.55M CAD

Employees

9

Previous close

0.49 CAD

Day range

0.49 – 0.50

52-week range

0.27 – 0.64

Volume

2.5K

50-day average

0.53 CAD

200-day average

0.54 CAD

Asset type

Equity

About BioMark Diagnostics Inc.

BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.

Company website

Frequently asked

+
What is the BUX.CN share price today?
This page shows the latest available BioMark Diagnostics Inc. (BUX.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is BioMark Diagnostics Inc. listed?
BioMark Diagnostics Inc. trades on the Canadian Securities Exchange under the symbol BUX.CN, ISIN CA09073K1084.
+
How large is BioMark Diagnostics Inc.?
Its market capitalisation is approximately 51.49M CAD, based on the latest available price and share count from our data provider.

All BioMark Diagnostics Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy